Keratoconus: Answers to the Questions Patients Ask Most
Understanding the Basics of Keratoconus
Before diving into treatment and daily life questions, it helps to understand what keratoconus is, who it affects, and how it typically behaves over time. These fundamentals shape every decision your care team makes.
Keratoconus affects roughly 0.29 percent of the global population, which works out to about 289 in every 100,000 people. This is far from a rare condition, and your care team sees patients managing it at every stage.
Wider use of corneal topography (a detailed map of the cornea's surface) has improved detection rates significantly in recent years, meaning more people are being diagnosed earlier, when treatment works best.
Onset most often occurs during the teen years through the mid-20s. The condition tends to progress during this period and typically stabilizes by the mid-30s to 40s, though the exact timeline varies from person to person.
If you are diagnosed in your teens, your cornea may still be actively changing. Your specialist will monitor your topography maps closely during these years to determine whether intervention is needed to prevent further vision loss.
In the vast majority of cases, keratoconus is bilateral, meaning it affects both eyes. However, one eye is almost always more severely affected than the other, so symptoms may seem one-sided at first.
Even when your second eye appears healthy, it should receive regular corneal topography screening. Subtle changes can appear in the second eye years after the first was diagnosed, and catching them early makes a real difference.
Treatment Options Explained
Keratoconus treatment has advanced considerably, giving patients more options to stabilize the condition and restore functional vision than ever before. Understanding each approach helps you participate actively in decisions about your care.
Corneal collagen cross-linking (CXL) is the only treatment proven to stop keratoconus from progressing. During the procedure, your specialist applies riboflavin (vitamin B2) drops to the cornea and activates them with ultraviolet light. This strengthens the bonds between collagen fibers, making the cornea more resistant to further thinning and bulging.
There are two main approaches. The traditional epithelium-off method removes the thin outer layer of the cornea before treatment and has been FDA-approved since 2016. An epithelium-on approach, which keeps that outer layer intact, received FDA approval in late 2025, offering patients an additional option that your specialist can discuss with you.
Only about 10 to 20 percent of people with keratoconus ultimately require corneal transplantation. Cross-linking performed before the disease reaches an advanced stage significantly reduces the chances of ever needing a transplant.
Transplant is considered when contact lenses can no longer provide usable vision or when corneal scarring blocks the visual pathway. For the large majority of patients who are diagnosed and treated early, this outcome can be avoided.
Because keratoconus distorts the cornea's shape, standard soft contact lenses often cannot correct vision adequately. Specialty lenses are designed to vault over or conform to irregular corneal surfaces and provide a much clearer result.
Options include rigid gas permeable (RGP) lenses, scleral lenses, hybrid lenses, and piggyback systems. Each suits different corneal shapes and individual comfort needs. Your contact lens specialist selects the best fit based on your specific corneal measurements.
Scleral lenses, which rest on the white of the eye and vault entirely over the cornea, tend to offer higher comfort and satisfaction compared to corneal RGP lenses. The most common limitation patients report is midday fogging caused by fluid buildup in the lens reservoir, which is usually manageable with lens care adjustments.
Keratoconus and Your Daily Life
A keratoconus diagnosis raises practical questions about everyday activities. Most patients with well-managed keratoconus maintain active, full lives, and knowing what to expect helps you plan ahead.
Most keratoconus patients maintain legal driving vision when their eyes are properly corrected with specialty contact lenses. With good lens correction, functional vision for driving and most daily activities is achievable for the majority of patients.
Night driving may remain more challenging because keratoconus can cause glare, halos, and reduced contrast sensitivity, especially in low light. Talk with your specialist about your driving vision, and consider limiting nighttime driving if glare and halos make it feel unsafe.
Screen use, reading, and other routine visual activities do not cause or worsen keratoconus. The shape of your cornea is not changed by how much time you spend looking at a screen.
That said, extended screen time can increase dry eye symptoms and eye fatigue, which may temporarily make existing visual distortion feel more noticeable. Using the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) and keeping artificial tears on hand can help manage screen-related discomfort without affecting your disease course.
Because keratoconus has a genetic component, first-degree relatives of someone with the condition are at higher risk. Corneal topography screening for children in your family is generally recommended starting around ages 10 to 12.
If your child has allergies, frequently rubs their eyes, or shows frequent changes in prescription, mention your own keratoconus history to their eye specialist. Eye rubbing in particular is a known risk factor and is worth addressing early. Topography screening remains the most reliable tool for catching subclinical changes before they cause noticeable symptoms.
Monitoring and Long-Term Outlook
Staying consistent with follow-up care is one of the most important things a keratoconus patient can do. How often you need monitoring and what to expect over the long term depends on several individual factors.
For active keratoconus, corneal topography monitoring every 3 to 6 months is standard practice. Patients who have shown clear stability after cross-linking or through natural stabilization may transition to annual monitoring visits.
Your specific schedule will depend on your age, how quickly your condition has changed in the past, and whether you have already had cross-linking. Younger patients and those without a stabilizing treatment in place typically need more frequent check-ins.
Keratoconus progression often naturally slows or stabilizes by the mid-30s to 40s, but this is not guaranteed for every patient. Waiting for natural stabilization carries the risk of avoidable vision loss that cross-linking could have prevented.
Even after the condition stabilizes, the corneal changes that occurred during the progressive phase are permanent. Specialty contact lenses or surgery address the accumulated vision loss, but the structural change to the cornea itself does not reverse on its own.
Recurrence of the disease in donor corneal tissue after a transplant is extremely rare. However, irregular astigmatism (uneven curvature causing blurred or distorted vision) may still be present after surgery, often requiring specialty contact lenses or glasses for the best possible vision outcome.
Patients who have had corneal transplants continue with regular eye exams to monitor the health of the graft and to catch any signs of rejection as early as possible. With proper long-term monitoring, grafts can remain healthy for many decades.
Frequently Asked Questions
The following questions come up often and cover situations that need a bit more specific guidance than a routine office conversation allows.
Flying is safe for keratoconus patients and does not affect the disease itself. However, cabin air is notably dry, which can cause contact lens discomfort on longer flights. Packing preservative-free artificial tears and removing your lenses during overnight flights can make the experience much more comfortable. If you wear scleral lenses, carry extra saline solution in your carry-on bag for refilling during the journey.
No current treatment reverses keratoconus or restores the cornea to its original shape. Cross-linking halts progression, and specialty lenses or surgical procedures restore as much functional vision as possible. Research into new approaches continues, but the current standard of care focuses on stopping the disease from advancing and optimizing vision through correction rather than reversal.
Hormonal changes during pregnancy can affect corneal shape and contact lens fit for some patients. If you are pregnant or planning to become pregnant, let your eye specialist know so your lens fit can be monitored and adjusted if needed. Cross-linking is typically deferred until after delivery, so if you are expecting and your keratoconus shows signs of progression, your care team will discuss timing and monitoring options with you carefully.
Skipping follow-up visits means that any progression goes undetected. The window during which cross-linking can stop the disease is finite, and missed appointments narrow that window without you knowing it. This risk is highest during the teens and twenties when the condition is most active. If scheduling conflicts arise, contact your care team to reschedule as soon as possible rather than waiting until your next routine slot.
Yes, and this is actually the expected pattern. Keratoconus almost always affects both eyes over time, even if only one has been formally diagnosed. The second eye may show subclinical changes on topography long before symptoms appear. This is why both eyes are screened at every visit, regardless of how the untreated eye currently feels or how well it sees.
Clinical trials investigating new treatments and technologies for keratoconus are conducted at academic medical centers and specialized practices. Searching ClinicalTrials.gov provides a current list of open studies and their eligibility requirements. If you are interested, bring it up with your specialist, who can help you evaluate whether a specific trial is appropriate given your current stage of disease and treatment history.
Partnering With Us for Your Keratoconus Care
Greenwich Ophthalmology Associates has served patients throughout the greater Stamford, CT region for more than 50 years, and our fellowship-trained specialists bring deep expertise in corneal disease, specialty contact lenses, and advanced surgical care. We believe that well-informed patients make better decisions about their vision, and we are here to answer every question at every stage of your care. Reach out to schedule a consultation and take the next step toward protecting your sight.
What our Patients say
4.8
Reviews
(3788)